Monterey Bio Acquisition stock and warrants may be traded separately beginning Nov. 22.
Units not separated will continue to trade on the Nasdaq under MTRYU. Shares and warrants that are separated will trade under MTRY and MTRYW.
Monterey raised $115 million in an IPO last month. The SPAC is targeting the biotech industry. Read more.
